The DEA's plan to list kratom as a Schedule I controlled substance would make researching the possible opioid substitute much more difficult.
Dr. Roger McIntyre suggests that the clinical relevance of cognitive dysfunction for any individual patient can only be adjudicated on a case-by-case basis.
The researchers observed between-group differences between real and sham acupuncture treatment.
Studies have found only small improvements in treating depression with Omega-3s and have been of low-quality.
Patients with psychosis and addiction disorders responded moderately better to disorder-specific treatment.
Patients in coordinated care remained in treatment longer and experienced greater improvements in their symptoms, compared with standard-care patients.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Link Identified Between Cured Meat and Mania in Bipolar Disorder
- First-Episode Delusional Disorder vs Schizophrenia: Assessment of Outcomes
- Early Risk Factors for Bipolar Disorder Found in Offspring of BD Parents
- Prevalence of Schizophrenia in Individuals With Type 2 Diabetes
- Daily Drinking Associated With Increased Mortality Risk
- The Opioid System: The Foundation for Social Risk and Reward
- Correctional Psychiatry: Challenges and Rewards
- Those Left Behind: Working With Suicide-Bereaved Families
- The Impact of Deafness on Hallucinations and Delusions
- Is Mandatory Reporting of Child Maltreatment in the Best Interests of the Child?
- Nutrition Tips for Physicians: Staying Healthy During Busy Days
- Mental Health Problems in Adolescents With HIV: Overview & Expert Interview
- Should Physicians Play a Role in Minimizing the Societal Cost of Medical Care?
- Digital Cognitive Behavioral Therapy Effective for Individuals With Insomnia
- How Do Medical Scribes Reduce EHR Documentation Burden for Physicians?